AssetMark Inc’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-68
| Closed | -$335 | – | 2260 |
|
|
2024
Q1 | $335 | Sell |
68
-1,978
| -97% | -$9.75K | ﹤0.01% | 1758 |
|
|
2023
Q4 | $18K | Sell |
2,046
-1,211
| -37% | -$10.6K | ﹤0.01% | 1308 |
|
|
2023
Q3 | $37.4K | Buy |
3,257
+1,261
| +63% | +$14.5K | ﹤0.01% | 1154 |
|
|
2023
Q2 | $50.5K | Buy |
+1,996
| New | +$50.5K | ﹤0.01% | 1077 |
|
|
2016
Q1 | – | Sell |
-14
| Closed | – | – | 1441 |
|
|
2015
Q4 | $0 | Buy |
+14
| New | – | ﹤0.01% | 1499 |
|